Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Yield | Market Capitalization | Net Income Common Stock |
---|---|---|---|
9/30/2025 | -29.32% | $ 834.95M | $ -244.78M |
6/30/2025 | -20.58% | $ 1.01B | $ -207.32M |
3/31/2025 | -29.52% | $ 705.94M | $ -208.4M |
12/31/2024 | -13.04% | $ 1.48B | $ -193.57M |
9/30/2024 | -10.57% | $ 1.67B | $ -176.98M |
6/30/2024 | -11.63% | $ 1.42B | $ -165M |
3/31/2024 | -18.77% | $ 771.18M | $ -144.73M |
12/31/2023 | -29.89% | $ 481.61M | $ -143.95M |
9/30/2023 | -49.21% | $ 302.18M | $ -148.71M |
6/30/2023 | -32.4% | $ 485.86M | $ -157.44M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Market Cap
(=) Earnings Yield
Earnings Yield for NURIX THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -43.24M ] / Market Cap [ $ 1.55B ]
(=) Earnings Yield [ -2.78% ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.42K |
---|---|
min | -31.84% |
max | 32.87% |
average | 0.32% |
median | 2.78% |
std | 9.84% |